COPD Foundation, GSK, and AARC Team Up for #COPDChat, November 9th, 12 pm ET

November 09, 2015

WASHINGTON, D.C. - November 9, 2015 - The COPD Foundation today announced a tweet chat with the GlaxoSmithKline (GSK) and American Association for Respiratory Care (AARC) to raise awareness and education of COPD. Happening today at noon Eastern, the chat will pose and discuss questions as it relates to COPD management, optimal treatment outcomes, and improving the patient/physician dialogue. To participate in the tweet chat, participants can use the hashtag #COPDChat on Twitter.

COPD is a growing problem in the U.S. and in one decade has risen from the fourth leading cause of death to the third, after heart disease and cancer. Although COPD is not curable, it is important for patients to understand that it is both manageable and treatable. Through early discussions with a primary care physician or pulmonologist, it is possible for patients to receive early diagnosis and begin building proper nutrition, exercise and treatment plans unique to their lifestyle and favorable for decreased disease progression.

5.5 percent of U.S. health costs are spent on chronic lung disease with a total of $49.9 billion annual costs accounting for COPD alone. Additionally, 26 percent of U.S. respondents reported visiting the emergency room with 17 percent having been hospitalized in 2014.

During the #COPDChat, GSK, AARC and the COPD Foundation will be joined by knowledgeable healthcare providers, eager and ready to discuss expert information on COPD and how to better manage the disease so patients are able to maintain a healthy and comfortable quality of life.

“By joining together with two leading advocacy organizations, our hope is to increase knowledge and awareness surrounding a disease that affects almost 15 million Americans,” said Deborah Long, U.S. Medical Affairs Lead, GSK. “We welcome healthcare providers, patients and friends and family of those diagnosed to participate in the chat to gain a better of understanding of COPD management.”

“The American Association for Respiratory Care is proud to be a part of this COPD Chat. It is essential that respiratory therapists be part of the conversation, it is all about our patients,” said Tom Kallstrom, MBA, RRT, FAARC, AARC Executive Director.

The COPD Foundation invites patients, families, and healthcare providers, along with the rest of the COPD community to join us and discuss COPD during #COPDChat on Twitter, Monday, November 9, at 12 PM ET.

“We are so pleased to be collaborating with AARC and GSK on this initiative. This is a great opportunity to connect the key stakeholders in our community from across the globe during COPD Awareness month,” said John W. Walsh, President and Co-Founder of the COPD Foundation. “I encourage providers, patients and caregivers to lend their voice to the COPD Chat.”